Publications

• Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
  Clin Infect Dis Volume: 80 Page(s): 223 - 227
  02/05/2025 Authors: Fong Y; Dang L; Zhang B; Fintzi J; Chen S; Wang J; Rouphael NG; Branche AR; Diemert DJ; Falsey AR
• Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.
  Nat Commun Volume: 16 Page(s): 759
  01/17/2025 Authors: Zhang B; Fong Y; Dang L; Fintzi J; Chen S; Wang J; Rouphael NG; Branche AR; Diemert DJ; Falsey AR
• Systems Vaccinology: Navigating the Future of Personalized Immunity and Next-Generation Vaccines.
  J Infect Dis Volume: 230 Page(s): 1305 - 1308
  12/16/2024 Authors: Dib SM; Wimalasena S; Graciaa DS; Rouphael N
• Safety and immunogenicity of a ChAd155-vectored rabies vaccine compared with inactivated, purified chick embryo cell rabies vaccine in healthy adults.
  Vaccine Volume: 42 Page(s): 126441
  12/02/2024 Authors: Phadke VK; Gromer DJ; Rebolledo PA; Graciaa DS; Wiley Z; Sherman AC; Scherer EM; Leary M; Girmay T; McCullough MP
• Human Immunodeficiency Virus Vaccine: Promise and Challenges.
  Infect Dis Clin North Am Volume: 38 Page(s): 475 - 485
  09/01/2024 Authors: Graciaa DS; Walsh SR; Rouphael N
• Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers.
  iScience Volume: 26 Page(s): 108256
  11/17/2023 Authors: Cheedarla N; Verkerke HP; Potlapalli S; McLendon KB; Patel A; Frank F; O'Sick WH; Cheedarla S; Baugh TJ; Damhorst GL
• Risk of COVID-19 after natural infection or vaccination.
  EBioMedicine Volume: 96 Page(s): 104799
  10/01/2023 Authors: Rick A-M; Laurens MB; Huang Y; Yu C; Martin TCS; Rodriguez CA; Rostad CA; Maboa RM; Baden LR; El Sahly HM
• Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
  Nat Med Volume: 29 Page(s): 2334 - 2346
  09/01/2023 Authors: Branche AR; Rouphael NG; Diemert DJ; Falsey AR; Losada C; Baden LR; Frey SE; Whitaker JA; Little SJ; Anderson EJ
• Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
  NPJ Vaccines Volume: 8 Page(s): 98
  07/11/2023 Authors: Lyke KE; Atmar RL; Dominguez Islas C; Posavad CM; Deming ME; Branche AR; Johnston C; El Sahly HM; Edupuganti S; Mulligan MJ
• Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
  JAMA Netw Open Volume: 6 Page(s): e2323349
  07/03/2023 Authors: Theodore DA; Branche AR; Zhang L; Graciaa DS; Choudhary M; Hatlen TJ; Osman R; Babu TM; Robinson ST; Gilbert PB
• Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies.
  Expert Rev Anti Infect Ther Volume: 21 Page(s): 595 - 616
  06/01/2023 Authors: Graciaa DS; Schechter MC; Fetalvero KB; Cranmer LM; Kempker RR; Castro KG
• Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial.
  Res Sq
  05/05/2023 Authors: Branche A; Rouphael N; Diemert D; Falsey A; Losada C; Baden LR; Frey S; Whitaker J; Little S; Anderson E
• Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection.
  J Infect Dis Volume: 226 Page(s): 1577 - 1587
  11/01/2022 Authors: Verkerke HP; Damhorst GL; Graciaa DS; McLendon K; O'Sick W; Robichaux C; Cheedarla N; Potlapalli S; Wu S-C; Harrington KRV
• Sweet Syndrome Imitating Cutaneous Cryptococcal Disease.
  Open Forum Infect Dis Volume: 9 Page(s): ofac608
  11/01/2022 Authors: Jordan AA; Graciaa DS; Gopalsamy SN; Neill SG; Parker DC; Aspey LD; Collins JM
• Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis.
  Antimicrob Agents Chemother Volume: 66 Page(s): e0040822
  09/20/2022 Authors: Graciaa DS; Kipiani M; Magee MJ; Mikiashvili L; Barbakadze K; Bablishvili N; Auld SC; Alghamdi WA; Alshaer MH; Peloquin CA
• SARS-CoV-2 seroprevalence among healthcare personnel at a large health system in Atlanta.
  Am J Med Sci Volume: 364 Page(s): 296 - 303
  09/01/2022 Authors: Graciaa DS; Kempker RR; Wang YF; Schurr H; Krishnan SD; Carroll K; Toomer L; Merritt S; King D; Hunter M
• Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.
  Cell Rep Med Volume: 3 Page(s): 100679
  07/19/2022 Authors: Lyke KE; Atmar RL; Islas CD; Posavad CM; Szydlo D; Paul Chourdhury R; Deming ME; Eaton A; Jackson LA; Branche AR
• SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.
  medRxiv
  07/15/2022 Authors: Branche AR; Rouphael NG; Diemert DJ; Falsey AR; Losada C; Baden LR; Frey SE; Whitaker JA; Little SJ; Anderson EJ
• Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim Analysis.
  Res Sq
  05/03/2022 Authors: Anderson E; Jackson L; Rouphael N; Widge A; Montefiori D; Doria-Rose N; Suthar M; Cohen K; O'Connell S; Makowski M
• Risk of Disseminated Gonococcal Infections With Terminal Complement Blockade.
  J Pediatr Hematol Oncol Volume: 44 Page(s): e493 - e495
  03/01/2022 Authors: Graciaa SH; Graciaa DS; Yildirim I; Chonat S
• Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimers.
  Res Sq
  02/16/2022 Authors: Cheedarla N; Verkerke HP; Potlapalli S; McLendon KB; Patel A; Frank F; Damhorst GL; Wu H; O'Sick WH; Graciaa D
• Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimers.
  medRxiv
  02/02/2022 Authors: Cheedarla N; Verkerke HP; Potlapalli S; McLendon KB; Patel A; Frank F; Damhorst GL; Wu H; O Sick WH; Graciaa D
• Is the BCG Vaccine an Answer to Future Pandemic Preparedness?
  Vaccines (Basel) Volume: 10
  01/27/2022 Authors: Khan NH; Rouphael NG; Baden LR; Graciaa DS
• Low rates of antibiotic use among ambulatory patients with coronavirus disease 2019 (COVID-19).
  Antimicrob Steward Healthc Epidemiol Volume: 2
  01/01/2022 Authors: Smith AGC; Wilber E; Rebolledo PA; Sharp J; Kandiah S; Graciaa DS; Kempker RR
• Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January-March 2021.
  Antimicrob Steward Healthc Epidemiol Volume: 2 Page(s): e159
  01/01/2022 Authors: Graciaa DS; Verkerke HP; Guarner J; Moldoveanu AM; Cheedarla N; Arthur CM; Maier CL; Neish A; Auld SC; Campbell A
• Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis.
  Open Forum Infect Dis Volume: 8 Page(s): ofab551
  12/01/2021 Authors: Kipiani M; Graciaa DS; Buziashvili M; Darchia L; Avaliani Z; Tabagari N; Mirtskhulava V; Kempker RR
• TB research amidst the COVID-19 pandemic.
  Int J Tuberc Lung Dis Volume: 25 Page(s): 167 - 170
  03/01/2021 Authors: Graciaa DS; Kempker RR; Sanikidze E; Tukvadze S; Mikiashvili L; Aspindzelashvili R; Alkhazashvili D; Blumberg HM; Avaliani Z; Tukvadze N
• A survey of the tuberculosis physician workforce in the country of Georgia.
  Int J Tuberc Lung Dis Volume: 22 Page(s): 1286 - 1292
  11/01/2018 Authors: Graciaa DS; Machaidze M; Kipiani M; Buziashvili M; Barbakadze K; Avaliani Z; Kempker RR
• Zika in 2018: Advising Travelers Amid Changing Incidence.
  Ann Intern Med Volume: 169 Page(s): 337 - 338
  09/04/2018 Authors: Graciaa DS; Collins MH; Wu HM
• Outbreaks Associated with Untreated Recreational Water - United States, 2000-2014.
  Am J Transplant Volume: 18 Page(s): 2083 - 2087
  08/01/2018 Authors: Graciaa DS; Cope JR; Roberts VA; Cikesh BL; Kahler AM; Vigar M; Hilborn ED; Wade TJ; Backer LC; Montgomery SP
• Outbreaks Associated with Untreated Recreational Water - United States, 2000-2014.
  MMWR Morb Mortal Wkly Rep Volume: 67 Page(s): 701 - 706
  06/29/2018 Authors: Graciaa DS; Cope JR; Roberts VA; Cikesh BL; Kahler AM; Vigar M; Hilborn ED; Wade TJ; Backer LC; Montgomery SP
• Asymptomatic Cardiovascular Syphilis With Aortic Regurgitation Requiring Surgical Repair in an HIV-Infected Patient.
  Open Forum Infect Dis Volume: 4 Page(s): ofx198
  01/01/2017 Authors: Graciaa DS; Mosunjac MB; Workowski KA; Kempker RR
• The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
  Neuropsychopharmacology Volume: 38 Page(s): 1921 - 1928
  09/01/2013 Authors: Musselman D; Royster EB; Wang M; Long Q; Trimble LM; Mann TK; Graciaa DS; McNutt MD; Auyeung NSF; Oliver L
• Activation of Neuroendocrine Pathways by IL-2 Administration in Patients with Malignant Melanoma
  Volume: 65 Page(s): 67S - 67S
  04/15/2009 Authors: Royster EB; Graciaa DS; Trimble LM; Miller AH; Musselman DL